Double heterozygosity for BRCA1 and hMLH1 gene mutations in a 46-year-old woman with five primary tumors (Q47550364)

3 February 2018

title

Double heterozygosity for BRCA1 and hMLH1 gene mutations in a 46-year-old woman with five primary tumors (English)

1 reference

3 February 2018

0 references

1 reference

1

1 reference

3 February 2018

Luca Reggiani Bonetti

4

1 reference

3 February 2018

Luca Reggiani Bonetti

5

1 reference

3 February 2018

Marco Marino

10

1 reference

3 February 2018

Maurizio Ponz de Leon

11

1 reference

3 February 2018

author name string

C Di Gregorio

2

1 reference

3 February 2018

L Cortesi

3

1 reference

3 February 2018

G Magnani

6

1 reference

3 February 2018

M L Simone

7

1 reference

3 February 2018

V Medici

8

1 reference

3 February 2018

C Priore Oliva

9

1 reference

3 February 2018

publication date

22 May 2013

1 reference

3 February 2018

Techniques in Coloproctology

published in

1 reference

3 February 2018

volume

18

1 reference

3 February 2018

issue

3

1 reference

3 February 2018

page(s)

285-289

1 reference

3 February 2018

https://scigraph.springernature.com/pub.10.1007/s10151-013-1030-y

exact match

0 references

cites work

Hereditary ovarian cancer: molecular genetics and clinical implications

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1030-Y

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1030-Y

Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1030-Y

Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1030-Y

Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1030-Y

Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1030-Y

Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1030-Y

Germline truncating mutations in both MSH2 and BRCA2 in a single kindred

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1030-Y

Germline truncating-mutations in BRCA1 and MSH6 in a patient with early onset endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1030-Y

A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1030-Y

Performance of different microsatellite marker panels for detection of mismatch repair-deficient colorectal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1030-Y

T25 repeat in the 3' untranslated region of the CASP2 gene: a sensitive and specific marker for microsatellite instability in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1030-Y

Cancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1030-Y

Germline MSH2 and MLH1 mutational spectrum in HNPCC families from Poland and the Baltic States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1030-Y

Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1030-Y

Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1030-Y

Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1030-Y

Mismatch repair defective breast cancer in the hereditary nonpolyposis colorectal cancer syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1030-Y

Evidence for breast cancer as an integral part of Lynch syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10151-013-1030-Y

Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review

21 January 2018

1 reference

12 December 2020

Germline BRCA1 and HMLH1 mutations in a family with male and female breast carcinoma

1 reference

12 December 2020

The genetic attributable risk of breast and ovarian cancer

1 reference

12 December 2020

Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer

1 reference

12 December 2020

Hereditary nonpolyposis colorectal cancer (HNPCC)/Lynch syndrome

1 reference

12 December 2020

10.1007/S10151-013-1030-Y

Identifiers

DOI

1 reference

3 February 2018

PubMed ID

23695190

1 reference

3 February 2018